Key facts
- Infiuss Health’s last known valuation is $15.0M (Sep 2022).
- It has raised $6.0M; the latest was Later Stage VC ($3.0M) in Dec 2024.
- Notable investors include Plug and Play Tech Center, Y Combinator, Pioneer Fund, Gaingels, Zain S Hasan Charitable Remainder Trust — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Infiuss Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Infiuss Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Infiuss Health
Developer of a clinical trial management software designed to provide access to clinical research studies. The company's research platform is a 2 sided marketplace powered by a robust patient community and focusing on connecting researchers to participants for eligible studies through a direct-to-patient approach and seamlessly, enabling the right participants from the patient community.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2017
- Employees
- 11
- Website
- infiuss.com/
- Ownership
- Privately Held (backing)
Infiuss Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Infiuss Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Infiuss Health in its N-PORT filings yet. We sweep new filings monthly.